Taken together, the results from both in vitro and in vivo studies suggest that FBXO5 exerts its anti-apoptotic effects and promotes tumor growth through the mechanism of targeted degradation of RNF183 Fig. 9. The gene discussed is FBXO5; the disease is neoplasm.